SEC Filing Analysis: NATIONAL RESEARCH CORP (NRC)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director at NATIONAL RESEARCH CORP was granted 22,625 stock options as standard compensation, a routine event with minimal market impact.
• Market Impact: The grant represents potential future dilution of approximately 0.1% of shares outstanding, which is not material.

Company Information

Field	Value
Company	NATIONAL RESEARCH CORP
Ticker Symbol	NRC
CIK	0000070487
Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Insider Information

Field	Value
Name	Berwick Donald M
CIK	0001656313
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-17
Transaction Code	A (Grant)
Security Type	Director Stock Option (Right to Buy)
Shares Involved	22,625
Price Per Share	$0.00
Total Value	$0
Shares Owned After	22,625 (derivative securities)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	22,625 (options)
% of Shares Outstanding	0.10%
Post-Transaction Ownership	22,625 options (potential 0.10% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a $280 million market cap, a $0 value grant is financially immaterial. The focus shifts to the potential dilution.
• Ownership Concentration: This grant establishes a small potential holding for the director, equivalent to 0.10% of the company's outstanding shares if exercised.
• Dilution Impact: The exercise of these options would introduce 22,625 new shares, causing a minor dilution of ~0.10% to existing shareholders. This is well below any level of concern.
• Transaction Significance: The transaction is classified as low significance. It is a standard form of non-cash compensation for a director and does not signal any new insider sentiment. The number of shares is small relative to the total outstanding.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants to directors are common and expected forms of compensation. They do not typically influence stock price unless they are unusually large or structured in a novel way.

Volume & Sentiment

• Expected Volume Impact: No significant impact on trading volume is expected.
• Sentiment Indicator: Neutral. This is a routine corporate governance action.

Investment Insights

Positive Market Indicators

• Aligns director interests with those of shareholders, although the stake is very small.

Risk Factors

• Minor potential shareholder dilution upon exercise of the options in the future.

Key Takeaways

1. Director Donald M. Berwick received a grant of 22,625 stock options with an exercise price of $11.61.
2. The transaction was for compensation purposes, as noted in the filing, and had a transaction value of $0.
3. The potential dilution from this grant is minimal at approximately 0.10% of total shares outstanding, making it an insignificant event for the market.

Additional Context

Transaction Notes

• Special Circumstances: Per the filing's footnote, the grant was made under the '2025 Omnibus Incentive Plan' for the director's participation in two in-person meetings.
• Market Environment: This is a routine corporate action independent of broader market conditions.